Skip to content

Clinical trials

Completed Breast Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Japan Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20042
20058
20066
20076
20087
20099
20106
20117
20128
20134
20148
20157
20162
20179
20189
20195
20203
20215
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals18
AstraZeneca16
Pfizer11
Hoffmann-La Roche10
Eisai Co., Ltd.6
GlaxoSmithKline5
Bayer3
Daiichi Sankyo3
Eli Lilly and Company3
Japan Breast Cancer Research Group3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms123
Neoplasms16
Neoplasm Metastasis12
Ovarian Neoplasms4
Hereditary Sensory and Autonomic Neuropathies3
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Lung Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.